Indeed, astrocyte-derived hepcidin has been shown to act on BBB endothelial ferroportin to restrict iron entry; experimentally, ventricular administration of hepcidin reduces iron influx into brain tissue and ameliorates iron overload [88]. The gene discussed is SLC40A1; the disease is Tangier disease.